MAPT and Alzheimer disease: Among these pathways, a glycolysis enzyme (pyruvate kinase) and an immunological factor (MIF, macrophage inhibitory protein) are selected by several ML classifiers to be the most important feature next to the Tau proteins as CSF signatures for AD [21].